← Evidence map

ArticleJournal of personalized medicine2022

Factors Predisposing the Response to Lumacaftor/Ivacaftor in People with Cystic Fibrosis.

Julie Mésinèle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2022
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35207740